Lymph node hypertrophy following Leishmania major infection is dependent on TLR9

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1394-1401

  Carvalho, Lucas P ^a   Petritus, Patricia M ^a   Trochtenberg, Alyssa L ^a   Zaph, Colby ^a,b   Hill, David A ^a   Artis, David ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; L SELECTIN; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; FEMALE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LEISHMANIASIS; LYMPH NODE HYPERTROPHY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; DENDRITIC CELLS; HYPERTROPHY; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 9;

EID: 84856588079     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101018     Document Type: Article

References (46)

1. Scott, P., D. Artis, J. Uzonna, and C. Zaph. 2004. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol. Rev. 201: 318-338. (Pubitemid 39318461)
2. Martin-Fontecha, A., S. Sebastiani, U. E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621. (Pubitemid 37040395)
3. Angeli, V., and G. J. Randolph. 2006. Inflammation, lymphatic function, and dendritic cell migration. Lymphat. Res. Biol. 4: 217-228. (Pubitemid 46493659)
4. Webster, B., E. H. Ekland, L. M. Agle, S. Chyou, R. Ruggieri, and T. T. Lu. 2006. Regulation of lymph node vascular growth by dendritic cells. J. Exp. Med. 203: 1903-1913. (Pubitemid 44188465)
5. Soderberg, K. A., G. W. Payne, A. Sato, R. Medzhitov, S. S. Segal, and A. Iwasaki. 2005. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc. Natl. Acad. Sci. USA 102: 16315-16320. (Pubitemid 41688911)
6. Ruddle, N. H., and E. M. Akirav. 2009. Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response. J. Immunol. 183: 2205-2212.
7. + T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 8: 743-752.
8. Hsu, A. C., and P. Scott. 2007. Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J. Immunol. 179: 8200-8207.
9. Unsoeld, H., K. Mueller, U. Schleicher, C. Bogdan, J. Zwirner, D. Voehringer, and H. Pircher. 2007. Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections. Int. Immunol. 19: 1281-1289. (Pubitemid 47604729)
10. Ehrchen, J. M., J. Roth, K. Roebrock, G. Varga, W. Domschke, R. Newberry, C. Sorg, C. Müller-Tidow, C. Sunderkötter, T. Kucharzik, and T.W. Spahn. 2008. The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice. Infect. Immun. 76: 4241-4250.
11. Barral, A., J. Guerreiro, G. Bomfim, D. Correia, M. Barral-Netto, and E. M. Carvalho. 1995. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am. J. Trop. Med. Hyg. 53: 256-259.
12. Barral, A., M. Barral-Netto, R. Almeida, A. R. de Jesus, G. Grimaldi Júnior, E. M. Netto, I. Santos, O. Bacellar, and E. M. Carvalho. 1992. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am. J. Trop. Med. Hyg. 47: 587-592.
13. Angeli, V., F. Ginhoux, J. Llodrà, L. Quemeneur, P. S. Frenette, M. Skobe, R. Jessberger, M. Merad, and G. J. Randolph. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24: 203-215. (Pubitemid 43214589)
14. Liao, S., and N. H. Ruddle. 2006. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J. Immunol. 177: 3369-3379. (Pubitemid 44277857)
15. Kimblin, N., N. Peters, A. Debrabant, N. Secundino, J. Egen, P. Lawyer, M. P. Fay, S. Kamhawi, and D. Sacks. 2008. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc. Natl. Acad. Sci. USA 105: 10125-10130.
16. Späth, G. F., and S. M. Beverley. 2001. A lipophosphoglycan- independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99: 97-103. (Pubitemid 34038221)
17. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
18. Bradley, L. M., S. R. Watson, and S. L. Swain. 1994. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp. Med. 180: 2401-2406. (Pubitemid 24351626)
19. Laskay, T., I. Wittmann, A. Diefenbach, M. Röllinghoff, and W. Solbach. 1997. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes. J. Immunol. 158: 1246-1253. (Pubitemid 127469948)
20. Randolph, G. J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13: 267-274. (Pubitemid 32744577)
21. Carvalho, L. P., E. J. Pearce, and P. Scott. 2008. Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-a, whereas bystander dendritic cells are activated to promote T cell responses. J. Immunol. 181: 6473-6480.
22. Schleicher, U., J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A. Fischer, S. Weiss, U. Kalinke, S. Kunz, and C. Bogdan. 2007. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med. 204: 893-906. (Pubitemid 46631617)
23. Liese, J., U. Schleicher, and C. Bogdan. 2007. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur. J. Immunol. 37: 3424-3434.
24. Abou Fakher, F. H., N. Rachinel, M. Klimczak, J. Louis, and N. Doyen. 2009. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J. Immunol. 182: 1386-1396.
25. Asselin-Paturel, C., G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri. 2005. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201: 1157-1167. (Pubitemid 40528442)
26. Pichyangkul, S., K. Yongvanitchit, U. Kum-arb, H. Hemmi, S. Akira, A. M. Krieg, D. G. Heppner, V. A. Stewart, H. Hasegawa, S. Looareesuwan, et al. 2004. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172: 4926-4933. (Pubitemid 38456417)
27. Grice, E. A., H. H. Kong, S. Conlan, C. B. Deming, J. Davis, A. C. Young, G. G. Bouffard, R. W. Blakesley, P. R. Murray, E. D. Green, et al NISC Comparative Sequencing Program. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324: 1190-1192.
28. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4: 263-273. (Pubitemid 26131009)
29. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4: 275-281. (Pubitemid 26131010)
30. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289. (Pubitemid 26131011)
31. Mueller, S. N., K. A. Hosiawa-Meagher, B. T. Konieczny, B. M. Sullivan, M. F. Bachmann, R. M. Locksley, R. Ahmed, and M. Matloubian. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317: 670-674. (Pubitemid 47229967)
32. Scott, P., A. Eaton, W. C. Gause, X. di Zhou, and B. Hondowicz. 1996. Early IL-4 production does not predict susceptibility to Leishmania major. Exp. Parasitol. 84: 178-187. (Pubitemid 26399784)
33. Becker, I., N. Salaiza, M. Aguirre, J. Delgado, N. Carrillo-Carrasco, L. G. Kobeh, A. Ruiz, R. Cervantes, A. P. Torres, N. Cabrera, et al. 2003. Leishmania lipophosphoglycan (LPG) activates NK cells through Toll-like receptor-2. Mol. Biochem. Parasitol. 130: 65-74. (Pubitemid 37289124)
34. Kropf, P., M. A. Freudenberg, M. Modolell, H. P. Price, S. Herath, S. Antoniazi, C. Galanos, D. F. Smith, and I. Müller. 2004. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72: 1920-1928. (Pubitemid 38419902)
35. Paun, A., R. Bankoti, T. Joshi, P. M. Pitha, and S. Stäger. 2011. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 7: e1001246.
36. Flandin, J. F., F. Chano, and A. Descoteaux. 2006. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-γ-primed macrophages. Eur. J. Immunol. 36: 411-420. (Pubitemid 43257464)
37. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371. (Pubitemid 351595218)
38. Noor, S., A. S. Habashy, J. P. Nance, R. T. Clark, K. Nemati, M. J. Carson, and E. H. Wilson. 2010. CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect. Immun. 78: 2257-2263.
39. Ato, M., A. Maroof, S. Zubairi, H. Nakano, T. Kakiuchi, and P. M. Kaye. 2006. Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J. Immunol. 176: 5486-5493.
40. Ato, M., S. Stäger, C. R. Engwerda, and P. M. Kaye. 2002. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat. Immunol. 3: 1185-1191. (Pubitemid 35469703)
41. Steigerwald, M., and H. Moll. 2005. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infect. Immun. 73: 2564-2567. (Pubitemid 40470864)
42. Olivier, M., D. J. Gregory, and G. Forget. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18: 293-305. (Pubitemid 40548295)
43. Alexander, J., and P. M. Kaye. 1985. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Clin. Exp. Immunol. 61: 674-682. (Pubitemid 16252346)
44. Buxbaum, L. U., H. Denise, G. H. Coombs, J. Alexander, J. C. Mottram, and P. Scott. 2003. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. J. Immunol. 171: 3711-3717. (Pubitemid 37254576)
45. Buxbaum, L. U., J. E. Uzonna, M. H. Goldschmidt, and P. Scott. 2002. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur. J. Immunol. 32: 3206-3215. (Pubitemid 35414878)
46. Carvalho, E. M., D. Correia Filho, O. Bacellar, R. P. Almeida, H. Lessa, and H. Rocha. 1995. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 53: 273-277.